UniProtKB/Swiss-Prot Q8NEV1: Variant p.Ile133Thr

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 133 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: US The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Isoleucine (I) to Threonine (T) at position 133 (I133T, p.Ile133Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and hydrophobic (I) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description: In a lung carcinoma sample; somatic mutation; shows greater kinase activity, provides a cell growth advantage and increases its interaction with the PML tumor suppressor protein and PML degradation. Any additional useful information about the variant.
Other resources: Links to websites of interest for the variant.

• Variant rs2071460 [ dbSNP | Ensembl ]

Sequence information

Variant position: 133 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 391 The length of the canonical sequence.
Location on the sequence: FEHVNNTDFKQLYQTLTDYD I RFYMYEILKALDYCHSMGIM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 391	Casein kinase II subunit alpha 3
Domain	39 – 324	Protein kinase

Literature citations

Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.
Hung M.S.; Lin Y.C.; Mao J.H.; Kim I.J.; Xu Z.; Yang C.T.; Jablons D.M.; You L.;
PLoS ONE 5:E11418-E11418(2010)
Cited for: FUNCTION; CATALYTIC ACTIVITY; INTERACTION WITH PML; VARIANT THR-133; TISSUE SPECIFICITY;